Personality Disorders and Co-Occurring Mental Health Conditions
Author: Ukrainian Psychological Hub · Published: October 13, 2026 · Editorial Policy
Personality disorders frequently occur alongside depression, anxiety disorders, post-traumatic stress disorder (PTSD), substance use disorders, eating disorders, and other mental health conditions. In clinical practice, this is called comorbidity or co-occurrence: two or more conditions meet their own diagnostic requirements in the same person. The central clinical task is to determine which difficulties represent enduring patterns of personality functioning, which represent distinct mental disorders, how they interact, and how treatment can address them together.
Co-occurrence matters because the same outward behavior can arise through different processes. Avoiding friends may reflect depression, social anxiety, traumatic reminders, longstanding interpersonal fears, or several of these together. Emotional instability can appear in multiple diagnoses but differs in time course, context, and associated symptoms. A careful assessment therefore examines symptoms across situations and over time rather than assigning multiple labels to every shared feature. The American Psychiatric Association's 2024 borderline personality disorder guideline explicitly calls for evaluation of common co-occurring disorders, physical health, functioning, culture, treatment history, and safety.
What does personality disorder comorbidity mean?
A personality disorder is diagnosed when clinically significant and persistent difficulties in personality functioning and patterns of experience or behavior meet the requirements of a recognized diagnostic system. A personality trait is a characteristic tendency; a maladaptive trait may contribute to difficulties; impaired personality functioning concerns enduring problems in one's relationship with self and others. A symptom describes an experience or behavior. A screening score estimates whether further assessment may be useful. None of these, by itself, establishes a personality disorder diagnosis.
Comorbidity means that more than one independently diagnosable condition is present. For example, a person might meet criteria for avoidant personality disorder and major depressive disorder, or borderline personality disorder and PTSD. The clinician must establish each diagnosis independently, taking account of overlap, onset, duration, context, and impairment. Co-occurrence does not necessarily imply that one condition caused the other. Population associations can arise from shared risk factors, reciprocal effects, overlapping diagnostic criteria, referral patterns, or limitations in how disorders are classified and measured.
It is useful to distinguish true co-occurrence from diagnostic overlap and differential diagnosis. In true co-occurrence, there is sufficient evidence for both conditions. In diagnostic overlap, some symptoms or traits fit more than one description. Differential diagnosis is the clinical process of determining which explanation, or combination of explanations, best accounts for the overall history. A person may have a personality disorder and an episodic condition simultaneously; alternatively, apparent personality pathology may largely reflect an untreated mood episode, substance effects, a medical problem, or another condition.
How common are co-occurring disorders?
Comorbidity is common in both population surveys and treatment settings, but its measured frequency depends on the personality disorder, the other condition, the time period examined, the assessment instrument, and whether participants come from community or specialty clinical samples. The National Institute of Mental Health's personality disorder statistics summarize U.S. National Comorbidity Survey Replication interviews from 2001–2003 and show substantial overlap with anxiety, mood, impulse-control, and substance use disorders. Those numbers reflect older DSM-IV-era interviews; they should not be presented as current ICD-11-specific prevalence or as the probability that an individual will have any particular diagnosis.
An earlier nationally representative U.S. survey of more than 43,000 adults reported significant associations between several DSM-IV personality disorders and mood and anxiety disorders, with substantial differences across particular diagnoses (Grant and colleagues' NESARC analysis). That study helps establish the historical epidemiological pattern, while its categorical classifications and cross-sectional associations limit direct application to current individual assessment.
The newer 2025 global systematic review and meta-regression in The Lancet Psychiatry00299-8) illustrates an important methodological shift toward dimensional descriptions and the challenges of comparing diagnostic systems across populations. A single percentage cannot summarize the prevalence of all personality disorders with all other psychiatric conditions in all settings.
Why the percentages vary so much
First, lifetime co-occurrence and 12-month co-occurrence answer different questions. A person who experienced depression a decade ago is counted in a lifetime estimate, even if no current depressive episode is present. Second, specialty clinics disproportionately encounter more severe, complex, and treatment-resistant problems. Third, studies have historically used categorical DSM diagnoses, often creating multiple overlapping personality disorder labels. Fourth, symptom questionnaires identify more possible cases than thorough clinical interviews in some settings. Finally, access to care, culture, diagnostic practice, sex- and gender-related referral differences, and exclusion criteria influence the apparent rates.
Direction matters too: the percentage of people with borderline personality disorder who have PTSD is not the percentage of people with PTSD who have borderline personality disorder. Readers should check the denominator, population, diagnostic definition, and time frame whenever a prevalence figure is reported.
Which mental health conditions commonly co-occur with personality disorders?
Depressive disorders
Depression can coexist with enduring difficulties in identity, self-direction, empathy, intimacy, or characteristic interpersonal patterns. Clinicians assess low mood, anhedonia, sleep and appetite changes, concentration, hopelessness, and the duration and severity of depressive episodes while also looking at functioning before, during, and between episodes. Persistent self-criticism, social withdrawal, or relationship difficulties may continue after a depressive episode improves, but those features require an individualized explanation rather than automatic attribution to a personality disorder.
The relationship also has prognostic implications. A longitudinal, nationally representative U.S. analysis examined how different personality disorder diagnoses were associated with the subsequent course of major depression. A 2024 systematic review and meta-analysis in Nature Mental Health, focusing specifically on co-occurring Cluster B personality disorders or traits and depression treatment, reported higher odds of depression-treatment nonresponse (pooled odds ratio 2.27; 95% confidence interval 1.63–3.15). This is a group-level association in the studied samples, not an individual forecast, and it cannot be generalized unchanged to every personality disorder.
A comprehensive plan evaluates the depressive disorder on its own terms, including suicide risk, possible bipolar episodes, medications, medical contributors, sleep, and social circumstances. Depression treatment and work on personality functioning can proceed in a coordinated sequence or together, depending on needs.
Anxiety disorders
Generalized anxiety disorder, social anxiety disorder, panic disorder, and other anxiety conditions may occur alongside personality pathology. The distinction between an anxiety syndrome and longstanding personality-related avoidance matters. For example, a person with avoidant personality disorder may have persistent fears of rejection, a negative self-concept, and a broad pattern of inhibition across relationships; social anxiety disorder focuses on disproportionate fear of scrutiny or negative evaluation in social situations. Both conditions may be present. Their diagnostic boundaries are informed by developmental history, the range of affected situations, functional impairment, and whether anxiety symptoms are better explained by other conditions.
Dependent or obsessive-compulsive personality features can also coexist with anxiety. Perfectionism, reassurance seeking, or indecision does not by itself prove either a personality disorder or an anxiety disorder. Evidence from the NESARC mood-and-anxiety comorbidity study supports associations, with varying strengths between diagnoses. Treatment should address the specific anxiety disorder and the enduring difficulties that interfere with care or daily life.
PTSD and complex PTSD
Trauma exposure and trauma-related symptoms are important to assess, including intrusive memories, avoidance, hyperarousal, persistent perceptions of threat, and changes in self-organization. A history of trauma is neither required for every personality disorder nor sufficient to establish one. PTSD and personality pathology may be genuinely co-occurring, and trauma-related difficulties may also resemble features of certain personality presentations.
Borderline personality disorder and PTSD have been studied particularly extensively. A systematic review of treatments for co-occurring BPD and PTSD found several relevant psychotherapeutic approaches and substantial evidence gaps concerning optimal treatment selection and sequencing. A 2024 meta-analysis of DBT-based PTSD treatments reported benefits in selected studies while underscoring variation in populations, protocols, and outcomes. These findings support careful, individualized evaluation of trauma-focused treatment rather than a categorical assumption that personality pathology rules it out.
The broader assessment of trauma responses belongs to trauma and PTSD care; this article addresses the question of whether trauma symptoms and personality disorder criteria independently apply and how teams coordinate treatment. Our clinical guide to differentiating personality disorders and trauma responses explores this diagnostic boundary in more detail.
Substance use disorders
Alcohol, opioids, stimulants, cannabis, and other substance use can complicate personality disorder assessment and treatment. Intoxication, withdrawal, disrupted sleep, craving, and substance-related consequences may affect impulsivity, irritability, perception, relationships, and emotional regulation. These effects need to be distinguished from longstanding personality difficulties. At the same time, untreated personality-related problems can complicate the management of a substance use disorder.
A 2023 scientific review of personality disorders and substance use disorders describes frequent co-occurrence and emphasizes that estimates vary markedly by diagnosis, substance, sample, and method. Proposed explanations include shared vulnerability and reciprocal influences, with causal mechanisms incompletely established. Borderline and antisocial personality disorders have received much more research attention than several other personality diagnoses.
Practical implications include screening for substance-related harms, withdrawal risk, medication interactions, overdose risk, access to addiction treatment, and continuity between mental health and substance use services. A patient should not have to complete personality disorder treatment before receiving evidence-based help for substance use. NICE guidance for antisocial personality disorder explicitly recommends treating co-occurring conditions according to their own appropriate guidance.
Eating disorders
Anorexia nervosa, bulimia nervosa, binge-eating disorder, and other eating disorders sometimes coexist with personality pathology. Concerns about body image, eating-related rituals, impulsivity, perfectionism, emotional distress, and interpersonal functioning may interact, but diagnostic criteria and medical risk must be assessed separately.
A systematic review and meta-analysis of eating disorders among people with borderline personality disorder estimated an overall frequency of approximately 29.7% across its included samples, with a wide confidence interval and low certainty of evidence. That figure is about the particular research populations studied; it is not a clinical prediction for someone diagnosed with BPD, nor a rate for all personality disorders. When an eating disorder presents with significant physical risk, nutritional and medical care may require immediate attention alongside psychological treatment.
Bipolar and other mood disorders
Distinguishing bipolar disorder from borderline personality disorder is a familiar clinical challenge, yet genuine co-occurrence is possible. Bipolar diagnoses depend on the presence and characteristics of manic, hypomanic, or depressive episodes, including duration, changes in energy and activity, associated symptoms, and their relationship to a person's baseline. Emotion regulation difficulties or rapidly changing feelings do not independently establish mania or BPD. Assessment usually involves a detailed timeline, collateral information when appropriate and consented to, treatment effects, sleep changes, and family history.
Because this differential is already owned by a published English Hub article, readers seeking that comparison should consult Bipolar Disorder vs Borderline Personality Disorder: How Clinicians Distinguish Them. The present article concentrates on the wider assessment and care of multiple diagnoses.
Psychotic disorders and psychotic experiences
Transient suspiciousness, dissociation, unusual perceptions, and severe stress reactions can occur in different clinical contexts. A psychotic disorder requires its own careful assessment, including the quality and persistence of delusions or hallucinations, disorganization, functioning, substance and medical contributors, and chronology. Clinicians should avoid treating any single unusual experience as proof of schizophrenia or personality disorder.
A 2026 systematic review and meta-analysis of psychotic disorders and BPD documented co-occurrence in heterogeneous clinical studies. Its pooled estimates had wide uncertainty intervals, so they should not be applied automatically to community populations or to people with other personality disorders. Significant or new psychotic symptoms call for timely medical and psychiatric evaluation; coordinated care may be necessary when both diagnoses are established.
ADHD, autism, and other neurodevelopmental conditions
ADHD and autism arise within a neurodevelopmental context and require attention to childhood history, developmental patterns, sensory and communication differences, executive functioning, and the effects of environment. Difficulties with planning, relationships, emotional responses, or social expectations may be shared on the surface while reflecting different developmental and clinical processes. ADHD or autism can also coexist with personality disorder, but an assessment must not mistake neurodevelopmental differences for personality pathology.
The already published articles Personality Disorders and ADHD: Diagnostic Overlap and Differences and Personality Disorders and Autism: Diagnostic Overlap and Differences address these questions separately. The broader diagnosis and care of ADHD and autism remain within their respective subject areas.
OCD, dissociative disorders, and other conditions
Obsessive-compulsive disorder (OCD) has specific obsessions and/or compulsions; obsessive-compulsive personality disorder (OCPD) concerns a broader, enduring pattern involving control, perfectionism, and rigidity. Their names overlap, and the conditions can coexist, but one diagnosis does not follow from the other. Dissociative symptoms also deserve assessment in relation to trauma, mood episodes, psychosis, and dissociative disorders rather than being assigned to personality pathology by default. Sleep disorders, medical illnesses, medication effects, chronic pain, and life stressors can further alter presentation.
Co-occurrence across two personality disorders is also possible. Historically, DSM categorical studies found substantial overlap even across the traditional A, B, and C clusters (U.S. epidemiologic study). This is one reason contemporary dimensional assessment of overall personality functioning and maladaptive traits is important.
Why do personality disorders and other conditions overlap?
Several explanatory pathways have been proposed, and more than one may apply to an individual. Shared temperamental vulnerabilities and genetic or environmental influences can contribute to multiple kinds of distress. Emotional dysregulation, interpersonal sensitivity, avoidance, reward-related behavior, and difficulties with attention or self-regulation can operate across diagnoses. Adverse experiences, chronic stress, and reduced social support can influence both personality development and later episodes of mental illness. Once problems develop, they can feed back into one another: depression may increase withdrawal, withdrawal may undermine relationships, and worsening interpersonal stress may deepen depression.
These pathways are probabilistic explanations, not diagnostic tests. No specific traumatic event, attachment history, neurobiological finding, or personality score identifies a particular personality disorder. Nor should a person's behavior be interpreted as evidence of an unrecognized personality disorder simply because a relationship is difficult.
Research studies can sometimes inflate overlap through shared criteria. For example, disturbances in sleep, concentration, negative self-evaluation, anxiety, and relationship functioning may be counted in different diagnoses. Some studies also fail to establish which condition began first. Careful longitudinal research and dimensional models can clarify how much observed comorbidity is due to truly distinct processes.
How DSM-5-TR and ICD-11 affect assessment of comorbidity
The DSM-5-TR retains familiar named personality disorder categories within its principal categorical model. Its alternative model for personality disorders considers disturbances in self and interpersonal functioning alongside pathological personality traits. The conventional DSM clusters A, B, and C are historical categorical groupings within the DSM approach; they are not equivalent to ICD-11's structure.
The World Health Organization's 2024 ICD-11 clinical descriptions and diagnostic requirements support assessment focused on personality disorder severity and characteristic maladaptive trait domains, with a borderline pattern qualifier where appropriate. This model encourages clinicians to assess how severely personality functioning is affected without requiring a separate named categorical personality diagnosis for every trait pattern. It also distinguishes personality difficulty, which does not automatically constitute a personality disorder.
These classification differences matter for studies of comorbidity. A paper that counted multiple DSM-IV personality disorder categories is measuring something different from an ICD-11 study describing one personality disorder by severity and trait qualifiers. Diagnostic models can inform clinical formulation but do not replace a careful assessment of depression, PTSD, OCD, substance use, or another co-occurring disorder according to its own requirements. For an expanded comparison, see DSM-5-TR vs ICD-11 Personality Disorders: Diagnosis and Classification.
How clinicians evaluate possible comorbidity
Establish a timeline, rather than collecting labels
A clinician reconstructs the history of symptoms and functioning across childhood, adolescence, and adulthood, including periods when the person felt relatively well. The assessment asks which problems are long-standing, which are episodic, which emerged after a particular event or medication change, and which shift with environmental demands. A timeline can reveal, for example, that disabling social fear began years before a recent depression, or that irritability occurs only during substance withdrawal.
Long-standing does not mean permanent, and early onset alone does not prove personality disorder. Relevant developmental and cultural expectations must be considered. Clinicians also explore relationships, work or education, sleep, medical health, strengths, current stressors, and goals. A diagnosis made during an acute crisis may need reassessment once the immediate state changes.
Evaluate each candidate disorder on its own evidence
Assessment uses clinical interviews, a mental status examination, and validated instruments when appropriate. The practitioner reviews the symptom clusters, duration, impairment, exclusions, and differential diagnoses relevant to each candidate condition. Structured or semi-structured interviews can improve consistency, but a questionnaire or screening score is only one part of the evaluation.
For personality functioning, the domains of identity, self-direction, empathy, and intimacy help describe how the person understands self and others, pursues goals, takes others' perspectives, and sustains close relationships. These constructs can refine a formulation while avoiding a simplistic tally of symptoms. Our clinical personality disorder assessment guide explains the process in detail.
A clinician should also ask whether separate diagnoses explain meaningful, distinct portions of the presentation. Assigning multiple diagnoses purely because one set of symptoms has multiple names can increase confusion and expose a patient to unnecessary treatment.
Consider culture, neurodevelopment, and life context
Behavior interpreted as withdrawn, suspicious, rigid, expressive, or emotionally distant may carry different meanings across cultures and environments. Experiences of displacement, discrimination, trauma, chronic illness, disability, and financial precarity affect functioning and access to care. Clinicians should seek the patient's account, use culturally appropriate communication and interpreters when needed, and consider the effects of stress and unequal treatment.
Autism, ADHD, intellectual or cognitive differences, and communication needs can affect how assessments are conducted. Good evaluation adapts the process to the person rather than forcing every difference into personality disorder criteria.
Assess safety and immediate treatment priorities
When relevant, clinicians assess suicidal thinking, self-injury, current violence risk, intoxication or withdrawal, severe malnutrition, mania, psychosis, and urgent medical concerns. Risk assessment is individualized and based on current presentation, history, protective factors, and clinical judgment. A personality disorder diagnosis alone does not establish a person's risk level.
The APA 2024 BPD guideline emphasizes broad initial evaluation and a documented, person-centered treatment plan. If there is an immediate threat to life or safety, urgent local emergency care takes precedence over a prolonged outpatient diagnostic process.
What does treatment look like when conditions co-occur?
The aim is a coordinated plan that addresses the person's priorities, current risks, individual diagnoses, and functioning. It may involve one clinician delivering an integrated psychological treatment, several clinicians coordinating distinct interventions, medication management for a co-occurring disorder, addiction care, medical treatment, and social or occupational support. A diagnosis should never become a reason to deny appropriate treatment for another condition.
One plan with clear clinical responsibilities
The plan should identify the most pressing current problems, which services are involved, who coordinates treatment, which outcomes will be monitored, how the patient participates in decisions, and what to do if symptoms intensify. Effective coordination is especially important when psychiatric and medical risks compete for attention, such as severe eating disorder complications, substance withdrawal, or acute mania.
NICE guideline CG78 recommends a structured approach for people with BPD and multiple co-occurring conditions. For major psychosis, significant substance dependence, or a severe eating disorder, it specifically discusses appropriate specialist referral with continued care coordination. These are BPD-specific recommendations; the treatment plan for a different personality disorder requires its own evidence and clinical judgment.
Psychotherapy for personality difficulties
For borderline personality disorder, the APA 2024 guideline recommends a structured psychotherapy with research support targeting the core features of BPD. Approaches such as dialectical behavior therapy, mentalization-based treatment, schema therapy, and transference-focused psychotherapy have different methods and evidence profiles. Matching treatment to the person's clinical presentation, goals, resources, and preferences matters.
Evidence for psychotherapy across all personality disorders is considerably less uniform. A technique studied for BPD should not be described as proven equally effective for narcissistic, avoidant, paranoid, antisocial, or obsessive-compulsive personality disorders. A thorough overview appears in Psychotherapy for Personality Disorders: Treatments and Evidence.
Treating PTSD, depression, anxiety, and substance use alongside personality disorder
Some patients benefit from coordinated work on both enduring patterns and current episodes. A person with BPD and PTSD might receive a staged or integrated trauma-focused approach when clinically appropriate, with safety planning and monitoring. For BPD with depression or anxiety, NICE guidance advises addressing these conditions within a well-structured BPD treatment program, while also following the guideline applicable to the co-occurring disorder.
A severe or acute disorder may need priority treatment without abandoning longer-term psychological care. A person experiencing dangerous alcohol withdrawal needs appropriate immediate medical treatment; a person with an active manic episode needs assessment and management of the mood episode; someone with medical instability from an eating disorder needs medical and nutritional evaluation. Treatment sequencing is a clinical decision shaped by safety, symptom severity, readiness, access, and preferences.
Integrated care also requires realistic measurement. Improvements in depressive symptoms, substance use, PTSD symptoms, relationships, daily functioning, and quality of life may occur at different rates. It is useful to track these separately rather than declaring an entire plan successful or unsuccessful based on one score.
Medications: what they can and cannot do
Medication may be indicated for a diagnosed co-occurring condition, such as major depression, bipolar disorder, ADHD, or a substance use disorder, when consistent with that condition's evidence-based guidance. The presence of a personality disorder neither automatically requires medication nor makes indicated treatment irrelevant.
For BPD specifically, the APA guideline calls for reviewing co-occurring disorders, previous treatments, and current medications before adding a drug, and it positions medication as a limited adjunct for specific measurable targets when used. NICE CG78 discourages medication as specific treatment for core BPD symptoms while recognizing pharmacotherapy for diagnosed co-occurring conditions. For antisocial personality disorder, NICE CG77 likewise advises against routine medication for the personality disorder itself and supports appropriately treating co-occurring conditions.
Medication planning should consider interactions, adverse effects, overdose risks, pregnancy considerations where relevant, previous response, and substance use. People should review prescribed medication with a qualified clinician and avoid abrupt changes without medical guidance.
Does comorbidity make treatment harder or recovery less likely?
Multiple diagnoses can complicate clinical care through higher symptom burden, more functional impairment, competing treatment needs, and fragmented services. However, complexity is not synonymous with hopelessness. The 2024 depression-treatment meta-analysis identifies an average association between Cluster B pathology and poorer depression-treatment response in the studied samples; it does not establish that any given patient is untreatable.
Longitudinal evidence challenges static assumptions about personality disorders. In the Collaborative Longitudinal Personality Disorders Study's ten-year follow-up, many participants with borderline personality disorder experienced diagnostic remission, while social and occupational functioning often improved more slowly. Diagnostic remission, relief from a particular co-occurring episode, improved relationships, and broader functional recovery are different but important outcomes.
Good care therefore follows change over time. Reassessment can reveal that one condition has remitted, another needs more focused intervention, and some longstanding difficulties have become more manageable. Updated diagnoses and treatment goals should reflect that progress.
Practical steps for people navigating more than one diagnosis
If several diagnoses appear in your records, ask the treating clinician what evidence supports each one, which symptoms are shared, and how the assessment distinguishes an enduring pattern from a current episode. Request a clear treatment plan identifying the problems being targeted first and how progress will be measured. If multiple specialists are involved, ask whether they can coordinate information and responsibilities with your consent.
A brief timeline of symptom changes, treatment response, medication effects, stressful events, and periods of stronger functioning can be more useful than repeated self-diagnosis through online checklists. Bring your questions to the appointment, including disagreements with previous labels. When treatment feels fragmented, requesting a review of the overall formulation is reasonable.
Family and supporters can help by responding to current needs, encouraging access to appropriate care, and respecting the person's autonomy and privacy. Avoid describing someone as a collection of diagnoses or interpreting every conflict as a symptom. A clinical diagnosis belongs to the person and their care team, not to an observer making inferences from a social media checklist.
Frequently asked questions
Can someone have more than one personality disorder?
Yes, depending on the diagnostic system used. Traditional categorical DSM research found substantial overlap among personality disorder categories. Modern dimensional approaches seek to describe severity of personality dysfunction and trait patterns more coherently. A clinician still evaluates the full presentation and the diagnostic framework before recording multiple diagnoses.
Can borderline personality disorder occur with depression and PTSD?
Yes. Both can be genuinely co-occurring with BPD when their separate criteria are met. The clinician evaluates the time course of depressive episodes, trauma-related symptoms, and enduring personality functioning. Treatment may be coordinated or integrated, with decisions individualized to symptoms, risk, patient preferences, and clinical expertise.
Is anxiety always part of a personality disorder?
No. Anxiety symptoms can occur for many reasons, and an anxiety disorder has its own diagnostic requirements. A person may have a personality disorder without a current anxiety disorder, an anxiety disorder without a personality disorder, or both.
Can ADHD and personality disorder both be diagnosed?
Yes, when a proper assessment supports both conditions. Childhood developmental history, attention and executive-function symptoms, characteristic interpersonal patterns, and the course of difficulties help clinicians avoid confusing one condition with the other.
Is depression that does not respond to treatment a sign of personality disorder?
Treatment-resistant depression has many possible contributors. A personality disorder is one potential clinical consideration among others, including inaccurate diagnosis, bipolar disorder, medication and treatment factors, medical illnesses, trauma, substance use, and ongoing adversity. Poor treatment response alone does not establish personality pathology.
Are all people with BPD at risk of self-harm or suicide?
Risk differs substantially between individuals and over time. Clinical assessment considers the person's actual symptoms, history, current circumstances, and protective factors. Self-harm is not a universal feature of every person with BPD, and risk should never be inferred solely from the diagnostic label.
Can an online personality test tell me which conditions I have?
A questionnaire may help identify symptoms worth discussing with a professional. It cannot independently establish a personality disorder, distinguish complex comorbidity, or determine the best treatment plan. Diagnostic interviewing, history, functional assessment, and clinical context are needed.
Should each diagnosis receive a different therapist?
Not necessarily. Some people benefit from one experienced clinician using a coherent integrated approach; others need coordinated specialists, particularly when a severe eating disorder, addiction, psychosis, or other medical concern requires distinct expertise. The key is a shared plan, clear responsibility, and continuity.
Does a personality disorder make medication for another condition ineffective?
No general rule supports that conclusion. Medication decisions depend on the co-occurring diagnosis, evidence for that treatment, safety, and the individual patient's history. Medication typically serves the condition for which it is indicated; it should not be assumed to treat core personality dysfunction.
Can personality functioning improve even when more than one diagnosis is present?
Yes. Symptoms and functioning can improve over time, often at different rates. Treatment can target both discrete episodes of illness and longstanding interpersonal or self-regulatory difficulties. Clinicians can reassess the treatment plan as diagnoses, functioning, and goals change.
The user-facing material provides educational information and does not replace a personalized evaluation by a qualified healthcare professional.
Related Articles
For the developmentally specific assessment of adolescents, see Personality Disorder Diagnosis in Adolescents: Clinical Considerations.
References
American Psychiatric Association. (2024). The American Psychiatric Association Practice Guideline for the Treatment of Patients With Borderline Personality Disorder. American Journal of Psychiatry, 181(11). https://doi.org/10.1176/appi.ajp.24181010
Carpenter, R. W., et al. (2023). The co-occurrence of personality disorders and substance use disorders. Current Addiction Reports. https://pubmed.ncbi.nlm.nih.gov/37787897/
Grant, B. F., et al. (2005). Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Psychiatric Research. https://pubmed.ncbi.nlm.nih.gov/15504418/
Gunderson, J. G., Stout, R. L., McGlashan, T. H., et al. (2011). Ten-year course of borderline personality disorder: Psychopathology and function from the Collaborative Longitudinal Personality Disorders Study. Archives of General Psychiatry, 68(8), 827–837. https://doi.org/10.1001/archgenpsychiatry.2011.37
National Institute for Health and Care Excellence. (2009). Antisocial personality disorder: Prevention and management (CG77). https://www.nice.org.uk/guidance/cg77/chapter/Recommendations
National Institute for Health and Care Excellence. (2009). Borderline personality disorder: Recognition and management (CG78). https://www.nice.org.uk/guidance/cg78/chapter/Recommendations
National Institute of Mental Health. (n.d.). Personality disorders: Statistics. https://www.nimh.nih.gov/health/statistics/personality-disorders
Nationally representative study on personality disorder comorbidity. (2005). Co-occurrence of DSM-IV personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Comprehensive Psychiatry. https://pubmed.ncbi.nlm.nih.gov/15714187/
Optimizing treatment for comorbid borderline personality disorder and posttraumatic stress disorder. (2021). Systematic review of psychotherapeutic approaches and treatment efficacy. Clinical Psychology Review. https://doi.org/10.1016/j.cpr.2021.102030
Personality disorders and depression treatment outcomes. (2024). The impact of comorbid Cluster B traits and personality disorders on depression treatment outcome: A systematic review and meta-analysis. Nature Mental Health. https://www.nature.com/articles/s44220-024-00340-z
Prevalence of eating disorders in people with borderline personality disorder. (2025). A systematic review and meta-analysis. International Journal of Eating Disorders. https://pmc.ncbi.nlm.nih.gov/articles/PMC12476134/
Psychotic disorders and borderline personality disorder. (2026). Co-occurrence of psychotic disorders and borderline personality disorder: A systematic review and meta-analysis. https://pubmed.ncbi.nlm.nih.gov/41656953/
Systematic review of dialectical behavior therapy variants for PTSD. (2024). A systematic review and meta-analysis on the efficacy of dialectical behavior therapy variants for the treatment of post-traumatic stress disorder. https://pmc.ncbi.nlm.nih.gov/articles/PMC11445934/
The global epidemiology of personality disorder. (2025). A systematic review and meta-regression. The Lancet Psychiatry, 12(12), 932–946. https://doi.org/10.1016/S2215-0366(25)00299-800299-8)
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. https://www.who.int/publications/i/item/9789240077263